Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)

Bibliographic Details
Main Authors:	Grignani, R, Pinter, K, Farza, H, Carballo, S, Oliveira, M, Redwood, C, Blair, E, Watkins, H
Format:	Conference item
Published:	2005

Similar Items

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Hypertrophic cardiomyopathy mutations in the gamma 2 subunit of AMP-activated kinase suggest a central role of energy compromise in disease pathogenesis
by: Blair, E, et al.
Published: (2001)

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
by: Blair, E, et al.
Published: (2001)

Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
by: Blair, E, et al.
Published: (2001)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
by: Neubauer, S, et al.
Published: (2019)

Mutation analysis of genes encoding subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
by: Blair, E, et al.
Published: (2002)

Mutation analysis of genes encoding Subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
by: Oliveira, M, et al.
Published: (2002)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Linked genetic modifiers in hypertrophic cardiomyopathy
by: Ektisham, J, et al.
Published: (2004)

Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart.
by: Pinter, K, et al.
Published: (2012)

Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart
by: Pinter, K, et al.
Published: (2012)

Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
by: Oliveira, S, et al.
Published: (2003)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
by: Dirceu Rodrigues Almeida
Published: (2019-04-01)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

"cAMP sponge": a buffer for cyclic adenosine 3', 5'-monophosphate
by: Lefkimmiatis, K, et al.
Published: (2009)

"cAMP sponge": a buffer for cyclic adenosine 3', 5'-monophosphate.
by: Konstantinos Lefkimmiatis, et al.
Published: (2009-11-01)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: Abozguia, K, et al.
Published: (2010)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Localisation of AMPK γ subunits in cardiac and skeletal muscles
by: Pinter, K, et al.
Published: (2013)

Localisation of AMPK γ subunits in cardiac and skeletal muscles.
by: Pinter, K, et al.
Published: (2013)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
by: Carballo, S, et al.
Published: (2003)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Arterio-venous (AV) difference of cyclic adenosine monophosphate (cAMP) serosa human adipose tissue in vivo
by: Moher, H, et al.
Published: (2001)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Optimization of the Tenderization of Duck Breast Meat by Adenosine 5′-Monophosphate (AMP) using Response Surface Methodology
by: Daoying Wang, et al.
Published: (2016-01-01)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
by: Sado Daniel, et al.
Published: (2013-01-01)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
by: Patricia Réant, et al.
Published: (2023-04-01)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
by: Carballo, S, et al.
Published: (2008)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
by: Redwood, C, et al.
Published: (2003)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
by: Carballo, S, et al.
Published: (2004)

Complement system specifically C5a receptor, inflammation and hypertrophic cardiomyopathy (HCM) in cats
by: Khor, Kuan Hua
Published: (2015)

Two Rare Cases of Long Surviving Riboflavin Transporter Deficiency with Co-Existing Adenosine Monophosphate Deaminase (AMP) Deficiency
by: Lin Zhang, et al.
Published: (2022-11-01)

Carvone Decreases Melanin Content by Inhibiting Melanoma Cell Proliferation via the Cyclic Adenosine Monophosphate (cAMP) Pathway
by: Wesuk Kang, et al.
Published: (2020-11-01)

Leptin interferes with 3',5'-Cyclic Adenosine Monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells
by: HoYuen Basil, et al.
Published: (2009-10-01)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
by: Maria Stec, et al.
Published: (2023-07-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)